Aerovate Therapeutics Organization
Aerovate Therapeutics is a biotechnology company focused on developing drugs for rare cardiopulmonary disease.
Connections from
Total Funding:
72600000
Investor Type:
Healthcare Company
Technology:
Anti-infective Drugs
Last Funding Type:
Series A
Founded Date:
2019
Industry:
PharmTech
Employee Number:
1-10
Funding Status:
IPO
Headquarters:
Boston, Massachusetts, United States